home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Catalent, Inc. Common Stock (NY:CTLT)

63.48 UNCHANGED

Last Price Updated: 7:00 PM EST, Dec 17, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Catalent, Inc. Common Stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Why PayPal And Coinbase Are Trading Lower; Here Are 20 Stocks Moving Premarket ↗

February 06, 2023

Gainers

Via Benzinga

Analyst Ratings for Catalent ↗

January 24, 2023

Via Benzinga

Barclays Maintains Overweight Rating for Catalent: Here's What You Need To Know ↗

January 24, 2023

Via Benzinga

Catalent, Inc. Announces Second Quarter Fiscal Year 2023 Earnings Conference Webcast

January 20, 2023

From Catalent, Inc.

Via Business Wire

Catalent Appoints Ricardo Zayas as North American Biologics Operations Leader

January 17, 2023

From Catalent, Inc.

Via Business Wire

Why Shares of Catalent Fell 36% This Week ↗

November 04, 2022

Lowered guidance and earnings concerned investors.

Via The Motley Fool

Johnson & Johnson Cuts Production, Ends Contracts For Not So Successful COVID-19 Shot ↗

January 13, 2023

Johnson & Johnson (NYSE: JNJ) has significantly scaled back its efforts of manufacturing its COVID-19 vaccine after facing a fall in demand.

Via Benzinga

Sarepta and Catalent Expand Strategic Manufacturing Partnership With Commercial Supply Agreement for Duchenne Muscular Dystrophy Gene Therapy Candidate

January 05, 2023

From Catalent, Inc.

Via Business Wire

Catalent, Inc. to Present at the 41st Annual J.P. Morgan Healthcare Conference

January 03, 2023

From Catalent, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022 ↗

December 19, 2022

Via Benzinga

Catalent Announces Changes to its Board of Directors

December 19, 2022

From Catalent, Inc.

Via Business Wire

Can Stocks Buck The Rising Odds Of A Recession? ↗

December 17, 2022

The S&P 500 rose 1.1% and ended the week above its 200-day moving average. Fed Chair Powell spurred a strong rally in stocks on Wednesday, saying interest rates could rise less in December compared to...

Via Talk Markets

Battered FTX's CEO Sam Bankman-Fried Arrested, Elon Musk's SpaceX Mammoth Valuation Of $140B, China Weighs Over $143B In Semiconductor Push: Top Stories Tuesday, Dec. 13 ↗

December 13, 2022

Benzinga Sam Bankman-Fried Arrested In The Bahamas

Via Benzinga

After US Launch Bottlenecks, Novo Nordisk Pushes European Rollout For Wegovy In 2023 ↗

December 13, 2022

Novo Nordisk A/S (NYSE: NVO) will roll out its obesity treatment, Wegovy (semaglutide), in Europe in 2023 to ensure it has enough supply.

Via Benzinga

After a $100 Haircut, is Catalent an Oversold Pharma Play?

November 14, 2022

With the macro backdrop weakening for Catalent’s pharmaceutical and biotech customers, fundamental concerns could outweigh what the charts suggest.

Via MarketBeat

Catalent, Inc. to Present at the Stephens Annual Investment Conference

November 08, 2022

From Catalent, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For November 7, 2022 ↗

November 07, 2022

Upgrades

Via Benzinga

Exelixis and Catalent Enter into New License Agreement for Three Antibody-Drug Conjugate Programs with the Potential to Accelerate Exelixis’ Biologics Pipeline

November 03, 2022

From Exelixis, Inc.

Via Business Wire

Where Catalent Stands With Analysts ↗

November 02, 2022

Over the past 3 months, 11 analysts have published their opinion on Catalent (NYSE:CTLT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022 ↗

November 02, 2022

Upgrades

Via Benzinga

Analyst Ratings for Catalent ↗

November 02, 2022

Over the past 3 months, 8 analysts have published their opinion on Catalent (NYSE:CTLT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's...

Via Benzinga

Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday ↗

November 02, 2022

Gainers

Via Benzinga

Why Catalent Stock Plummeted by Nearly 25% Today ↗

November 01, 2022

Flat revenue growth, a sharp decline in profitability, and reduced guidance combined to make an awful day for the company.

Via The Motley Fool

Nasdaq Down 60 Points; Eli Lilly Lowers Earnings Forecast ↗

November 01, 2022

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 70 points on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 01, 2022

Gainers

Via Benzinga

Unity Biotechnology (UBX) Stock Pops on Positive Study Data ↗

November 01, 2022

Unity Biotechnology (UBX) stock is gaining on Tuesday after the company released results from a Phase 2 clinical trial of UBX1325.

Via InvestorPlace

Why Is Catalent (CTLT) Stock Down 24% Today? ↗

November 01, 2022

Catalent (CTLT) stock is falling on Tuesday as investors react to dismal results in its earnings report for the fiscal first quarter of 2023.

Via InvestorPlace

Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day Session ↗

November 01, 2022

Gainers Safe-T Group Ltd (NASDAQ: SFET) shares surged 63.7% to $0.4910 as the company said its privacy application reached over 5,000,000 downloads.

Via Benzinga

Dow Drops Over 200 Points; Crude Oil Rises Sharply ↗

November 01, 2022

U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 200 points on Tuesday.

Via Benzinga

Goodyear Tire, Catalent, Zebra Technologies And Some Other Big Stocks Moving Lower On Tuesday ↗

November 01, 2022

U.S. stocks traded lower, with the Dow Jones dropping more than 100 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com